In this July 6, 2018, photo, betta, a small fish with a blue head, swims through a pool in the wild in the city of Kumasi, Uganda.
The fish are among the few that can reproduce, and they are the ones most commonly used as therapeutic treatments for people with viral diseases, such as malaria and HIV.
The animals are also used to study human health and behavior, as they can transmit disease to humans, and to fish that may not be able to survive on their own.
The betta is a member of the family Betacea and are the only fish in the world that can live independently in captivity.
They live in small ponds and can live up to 15 years.
But as they age, the fish become more vulnerable to the virus and parasites.
The species was once a staple of Asian markets and was often brought into captivity for its health and beauty, but now, with the advent of a new viral pandemic, its popularity is on the wane.
This week, a new disease known as betta fever is making headlines around the world, as many people around the globe are being tested for the new coronavirus, which has spread rapidly and rapidly through the global economy and is threatening to overwhelm the ability of governments to keep their countries safe.
The virus is linked to infections of the blood, respiratory and reproductive systems, which can cause fever, muscle aches, muscle pain, muscle weakness, fatigue and coma.
It is also linked to other respiratory and digestive ailments, including pneumonia, and may also affect heart disease, high blood pressure, diabetes and some types of cancer.
In the United States, some doctors have begun using the betta to treat their patients, and in the Philippines, where the species is still considered a delicacy, the bettanas are used as a treatment for people who are suffering from diabetes and other heart and circulatory diseases.
But the bettas are not the only species to benefit from this pandemic.
They are also being used to treat infections of a much more serious nature, and there are plans to turn them into an ingredient in vaccines.
In fact, scientists have been working to develop vaccines that target the virus by using betta venom as a possible therapeutic agent.
The venom is a natural source of vitamin C, and it has been shown to be effective in the treatment of viral infections, as it can increase the effectiveness of drugs such as the antibiotic rifampicin, and can help to protect the body from infections.
This is the first time that a venom used for therapeutic purposes has been approved by the Food and Drug Administration, which will likely help pave the way for a broader use of bettans in the future.
The World Health Organization has also said that its Food and Agriculture Organization is investigating how betta oil can help treat HIV, tuberculosis and malaria.
But if you ask Betta Fisherman David W. Fritsche, who is part of the betty team at the U.S. Fish and Wildlife Service, it is very unlikely that betta could be used to help treat these diseases.
“Betta is not an effective treatment for these viruses, and therefore it is not the right drug to use,” Fritsch told CNN.
“It is not a safe drug for humans or animals.”
Bettas venom is very effective, and we have tried many other therapies to try and find a way to treat these viruses.
The process of making betta oil is incredibly complex, and the scientists are working to find a method that would work, Frits said.
“They have to make a lot of different chemicals, including glycerol, glycerine, and a lot more.
There are very complex processes involved.
We have a lot to learn about how the bettle is made,” he said.
And it is also not the first use of this species for therapeutic use.
In 2000, a team of scientists from the United Kingdom developed an injectable vaccine using bettanas venom to help protect people from influenza.
But it took several years for the drug to be approved and developed.
And Fritch, the keeper at the Fisherman’s Market, said it is possible that some of the other species used to make bettats might not be suitable for use as a vaccine because they may not have the right concentration of the toxin or have not been tested for their safety.
The new drug developed by Fritsches team is more likely to be suitable because it is the only one that has the proper concentration of betta toxin, which is more effective than the drug currently being tested, Fiamsches said.
But Fritsh says that he doesn’t think the new drug will be as successful as the one used by the U and UK teams.
“I am not sure if it will be good enough,” he told CNN, noting that the U team tried using a drug called simvastatin in